Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 6 | 2023 | 348 | 2.420 |
Why?
|
| Rett Syndrome | 7 | 2023 | 262 | 1.810 |
Why?
|
| Fear | 10 | 2021 | 254 | 1.430 |
Why?
|
| Hippocampus | 7 | 2023 | 915 | 1.110 |
Why?
|
| Dentate Gyrus | 3 | 2021 | 52 | 1.000 |
Why?
|
| Neural Inhibition | 3 | 2021 | 147 | 0.980 |
Why?
|
| Fornix, Brain | 4 | 2021 | 20 | 0.940 |
Why?
|
| Memory | 6 | 2019 | 429 | 0.900 |
Why?
|
| Epileptic Syndromes | 1 | 2021 | 26 | 0.800 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 7 | 2023 | 291 | 0.710 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 165 | 0.700 |
Why?
|
| Long-Term Potentiation | 6 | 2015 | 176 | 0.590 |
Why?
|
| Neuronal Plasticity | 5 | 2018 | 304 | 0.540 |
Why?
|
| Parkinson Disease | 1 | 2021 | 708 | 0.500 |
Why?
|
| Amygdala | 3 | 2003 | 127 | 0.460 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2006 | 50 | 0.450 |
Why?
|
| Neurogenesis | 3 | 2023 | 238 | 0.440 |
Why?
|
| Mice | 29 | 2023 | 34495 | 0.410 |
Why?
|
| Avoidance Learning | 2 | 2021 | 94 | 0.390 |
Why?
|
| Nicotine | 2 | 2010 | 244 | 0.380 |
Why?
|
| Behavior, Animal | 9 | 2020 | 709 | 0.360 |
Why?
|
| Conditioning, Classical | 3 | 2009 | 69 | 0.350 |
Why?
|
| Neurons | 9 | 2023 | 2287 | 0.340 |
Why?
|
| Dopamine | 2 | 2014 | 312 | 0.340 |
Why?
|
| Gyrus Cinguli | 3 | 2005 | 140 | 0.340 |
Why?
|
| Animals | 32 | 2023 | 59536 | 0.340 |
Why?
|
| Nicotinic Agonists | 1 | 2009 | 113 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 6942 | 0.320 |
Why?
|
| Mental Retardation, X-Linked | 2 | 2021 | 94 | 0.310 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2021 | 248 | 0.300 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 294 | 0.300 |
Why?
|
| Seizures | 4 | 2022 | 989 | 0.290 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2010 | 259 | 0.290 |
Why?
|
| Mice, 129 Strain | 2 | 2021 | 170 | 0.240 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 176 | 0.210 |
Why?
|
| Auditory Pathways | 1 | 2001 | 18 | 0.210 |
Why?
|
| Electroencephalography | 3 | 2022 | 898 | 0.210 |
Why?
|
| Electrodes | 1 | 2021 | 116 | 0.200 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 241 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 889 | 0.190 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 16 | 0.190 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 39 | 0.180 |
Why?
|
| Gene Expression | 4 | 2016 | 3570 | 0.180 |
Why?
|
| Polyadenylation | 1 | 2020 | 70 | 0.180 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 30 | 0.170 |
Why?
|
| Genes, Duplicate | 2 | 2015 | 21 | 0.170 |
Why?
|
| Behavior | 1 | 2019 | 103 | 0.170 |
Why?
|
| Chromatin | 1 | 2023 | 942 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 4143 | 0.150 |
Why?
|
| Respiratory Center | 1 | 2017 | 10 | 0.150 |
Why?
|
| Motor Neurons | 1 | 2018 | 138 | 0.150 |
Why?
|
| Respiratory System | 1 | 2018 | 125 | 0.150 |
Why?
|
| Substance P | 1 | 2017 | 71 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 1533 | 0.150 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 148 | 0.150 |
Why?
|
| Sodium Channels | 1 | 2017 | 109 | 0.140 |
Why?
|
| Pain | 1 | 2005 | 1658 | 0.140 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 7222 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2020 | 403 | 0.140 |
Why?
|
| Acoustic Stimulation | 4 | 2006 | 118 | 0.140 |
Why?
|
| GABAergic Neurons | 1 | 2016 | 47 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2018 | 370 | 0.140 |
Why?
|
| Spatial Learning | 1 | 2015 | 16 | 0.140 |
Why?
|
| Tauopathies | 1 | 2016 | 63 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 71 | 0.130 |
Why?
|
| Sodium | 1 | 2017 | 353 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2015 | 829 | 0.130 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2018 | 233 | 0.130 |
Why?
|
| Receptors, Adrenergic | 1 | 2014 | 46 | 0.130 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 42 | 0.130 |
Why?
|
| Perforant Pathway | 2 | 2014 | 15 | 0.130 |
Why?
|
| Extinction, Psychological | 2 | 2006 | 31 | 0.130 |
Why?
|
| tau Proteins | 1 | 2016 | 216 | 0.120 |
Why?
|
| Methylphenidate | 1 | 2014 | 103 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2020 | 786 | 0.120 |
Why?
|
| Aging | 2 | 2019 | 1582 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 674 | 0.110 |
Why?
|
| Male | 17 | 2023 | 123000 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 225 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1077 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2016 | 874 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 984 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 500 | 0.100 |
Why?
|
| Calcium | 1 | 2017 | 1537 | 0.090 |
Why?
|
| Synaptic Potentials | 1 | 2009 | 16 | 0.090 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 376 | 0.090 |
Why?
|
| Brain | 2 | 2023 | 4113 | 0.090 |
Why?
|
| Mesencephalon | 1 | 2009 | 58 | 0.090 |
Why?
|
| Cognition | 1 | 2015 | 968 | 0.090 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2009 | 79 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2016 | 1664 | 0.080 |
Why?
|
| Pyramidal Cells | 2 | 2022 | 168 | 0.080 |
Why?
|
| Female | 11 | 2023 | 141928 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2009 | 298 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2020 | 5710 | 0.080 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2006 | 19 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2006 | 33 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1491 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 5159 | 0.070 |
Why?
|
| Mutation | 4 | 2023 | 15179 | 0.070 |
Why?
|
| Muscimol | 1 | 2005 | 13 | 0.070 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2005 | 7 | 0.070 |
Why?
|
| Synapses | 3 | 2005 | 509 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2020 | 5637 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 5539 | 0.060 |
Why?
|
| Phenotype | 1 | 2015 | 6295 | 0.060 |
Why?
|
| Gene Duplication | 2 | 2016 | 421 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 1516 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2005 | 238 | 0.060 |
Why?
|
| Random Allocation | 1 | 2005 | 703 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 2063 | 0.060 |
Why?
|
| Electroporation | 1 | 2003 | 126 | 0.060 |
Why?
|
| Calmodulin | 1 | 2003 | 241 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2002 | 48 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2002 | 38 | 0.050 |
Why?
|
| Geniculate Bodies | 1 | 2001 | 23 | 0.050 |
Why?
|
| Memory, Long-Term | 1 | 2022 | 39 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 443 | 0.050 |
Why?
|
| Reaction Time | 1 | 2001 | 234 | 0.050 |
Why?
|
| Interneurons | 1 | 2022 | 144 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 2307 | 0.050 |
Why?
|
| Hindlimb | 1 | 2020 | 105 | 0.050 |
Why?
|
| Genes, Lethal | 1 | 2020 | 120 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2005 | 2450 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2022 | 295 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2013 | 245 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2014 | 426 | 0.040 |
Why?
|
| Rats | 2 | 2005 | 6086 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 1618 | 0.040 |
Why?
|
| Hypoglossal Nerve | 1 | 2018 | 6 | 0.040 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2018 | 19 | 0.040 |
Why?
|
| Gliosis | 1 | 2018 | 41 | 0.040 |
Why?
|
| Wakefulness | 1 | 2019 | 150 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2018 | 27 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 634 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 717 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 90 | 0.040 |
Why?
|
| Ataxin-1 | 1 | 2018 | 148 | 0.040 |
Why?
|
| Periodicity | 1 | 2017 | 68 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2018 | 1442 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 370 | 0.040 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 31 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 1020 | 0.040 |
Why?
|
| Diaphragm | 1 | 2018 | 181 | 0.040 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 560 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 413 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2001 | 666 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 827 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2017 | 424 | 0.030 |
Why?
|
| Inflammation | 1 | 2005 | 2522 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2010 | 269 | 0.030 |
Why?
|
| Body Weight | 1 | 2020 | 1293 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 886 | 0.030 |
Why?
|
| Theta Rhythm | 1 | 2014 | 29 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 261506 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 114 | 0.030 |
Why?
|
| Mosaicism | 1 | 2016 | 272 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 262 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2018 | 690 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 1062 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 183 | 0.030 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 16 | 0.030 |
Why?
|
| Hyperkinesis | 1 | 2013 | 23 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1890 | 0.030 |
Why?
|
| Lithium | 1 | 2013 | 71 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 48 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 677 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 388 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 834 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 169 | 0.030 |
Why?
|
| Anxiety | 1 | 2020 | 1179 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 1152 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 441 | 0.030 |
Why?
|
| Valproic Acid | 1 | 2013 | 263 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 4917 | 0.020 |
Why?
|
| Drosophila | 1 | 2016 | 839 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 950 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 608 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 487 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 70 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 855 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 4804 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12221 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 4938 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2005 | 43 | 0.020 |
Why?
|
| Nociceptors | 1 | 2005 | 86 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 360 | 0.020 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2003 | 14 | 0.010 |
Why?
|
| Microinjections | 1 | 2003 | 96 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 448 | 0.010 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2002 | 7 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 2002 | 8 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 289 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13310 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 869 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 333 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 16273 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 694 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 14551 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 716 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 77950 | 0.010 |
Why?
|
| Motor Activity | 1 | 2003 | 693 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 29902 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 31252 | 0.010 |
Why?
|
| Piperidines | 1 | 2002 | 1035 | 0.010 |
Why?
|
| Child | 1 | 2018 | 29154 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2002 | 1471 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 7548 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 12926 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 86204 | 0.010 |
Why?
|